ClearPoint Neuro (CLPT) Projected to Post Earnings on Wednesday

ClearPoint Neuro (NASDAQ:CLPT) is expected to issue its quarterly earnings data after the market closes on Wednesday, February 26th. Analysts expect the company to announce earnings of ($0.15) per share and revenue of $8.23 million for the quarter.

ClearPoint Neuro Price Performance

ClearPoint Neuro stock opened at $17.45 on Friday. The firm has a market capitalization of $481.27 million, a price-to-earnings ratio of -25.29 and a beta of 1.03. The company’s 50 day simple moving average is $16.58 and its 200 day simple moving average is $13.50. ClearPoint Neuro has a fifty-two week low of $5.11 and a fifty-two week high of $19.22.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the stock. Lake Street Capital lifted their price target on shares of ClearPoint Neuro from $17.00 to $30.00 and gave the stock a “buy” rating in a research report on Tuesday, January 21st. B. Riley lifted their target price on ClearPoint Neuro from $15.00 to $20.00 and gave the stock a “buy” rating in a report on Tuesday, January 28th.

About ClearPoint Neuro

ClearPoint Neuro, Inc operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain.